3-Methyl-8-Quinolinesulphonyl Chloride CAS 74863-82-4 Argatroban Intermediate Factory 98.0%
Kaihanga Kaihanga Argatroban Kaiwaenga e Pa ana:
Ethyl (2R,4R)-4-Methyl-2-Piperidinecarboxylate CAS 74892-82-3
N-Nitro-1,2,3,4-tetradehydro Argatroban Ethyl Ester CAS 74874-09-2
3-Methyl-8-Quinolinesulphonyl Chloride CAS 74863-82-4
Argatroban Monohydrate CAS 141396-28-3
Argatroban Anhydrous CAS 74863-84-6
Ingoa matū | 3-Methyl-8-Quinolinesulphonyl Chloride |
Nga kupu taurite | 3-Methylquinoline-8-Sulfonyl Chloride |
Tau CAS | 74863-82-4 |
Tau CAT | RF-PI269 |
Tūnga Taonga | I roto i te Stock, Production Tauine Up ki Taranata |
Tātai rāpoi | C10H8ClNO2S |
Taumaha rāpoi | 241.69 |
Kiato | 1.4±0.1 g/cm3 |
Taurangi Refactive | 1.63 |
Wairewa | Wairewa ki Chloroform |
Tikanga Tukunga | Ka tukuna i raro i te pāmahana ambient |
Waitohu | Ruifu Chemical |
Tūemi | Whakatakotoranga |
Te ahua | Paura Tioata Ma |
Te Maama / Tikanga Tatauria | >98.0% (HPLC) |
Te Whakarewa | 162.0~163.0 ℃ |
Ngaronga i te whakamaroke | <0.50% |
3-Methylquinoline-8-Sulfonic Acid | <1.00% |
Nga poke katoa | <2.00% |
Spectrum Infrared | He rite ki te Hanganga |
NMR | He rite ki te Hanganga |
Paerewa Whakamatau | Paerewa hinonga |
Whakamahinga | Takawaenga o Argatroban (CAS 74863-84-6) |
Mōkī: Pounamu, Peeke konumohe konumohe, 25kg / Kaata Drum, kia rite ranei ki te hiahia a te kaihoko
Tikanga Rokiroki:Whakaorangia i roto i nga ipu kua hiri ki te waahi makariri me te maroke;Tiaki i te marama me te makuku
Ko Shanghai Ruifu Chemical Co., Ltd. te kaihanga matua me te kaiwhakarato o te 3-Methyl-8-Quinolinesulphonyl Chloride (CAS: 74863-82-4) me te kounga teitei, e whakamahia nuitia ana i roto i te whakahiato waro, te whakahiato o nga takawaenga rongoa me te Active Pharmaceutical Ingredient (API) whakahiato.Kohe takawaenga i roto i te whakahiatotanga o Argatroban (CAS: 74863-84-6) Argatroban Monohydrate ranei (CAS 141396-28-3).
Ko te Argatroban (CAS: 74863-84-6) he anticoagulant he iti ngota ngota aukati thrombin tika.I te tau 2000, i raihanatia a argatroban e te Kai me te Taakaro Whakahaere (FDA) mo te aukati, te maimoatanga ranei o te thrombosis i roto i nga turoro me te heparin-induced thrombocytopenia (HIT).I te tau 2002, i whakaaetia kia whakamahia i roto i nga wawaotanga coronary percutaneous i roto i nga turoro kua HIT, kei te tupono ranei ki te whakawhanake.I te 2012, i whakaaetia e te MHRA i te UK mo te anticoagulation i roto i nga turoro me te heparin-induced thrombocytopenia Type II (HIT) e hiahia ana ki te maimoatanga antithrombotic parenteral.